Kuros Biosciences Forecast, price target & analysts
Kuros Biosciences Target price 2025 - Analyst rating & recommendation
Kuros Biosciences Classifications & Recommendation:
Kuros Biosciences Price Target
| Target Price | CHF33.15 |
| Price | CHF26.92 |
| Potential |
23.14%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Kuros Biosciences 2026 .
The average Kuros Biosciences target price is CHF33.15.
This is
23.14%
register free of charge
CHF34.13
26.76%
register free of charge
CHF32.83
21.94%
register free of charge
|
|
| A rating was issued by 7 analysts: 6 Analysts recommend Kuros Biosciences to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Kuros Biosciences stock has an average upside potential 2026 of
23.14%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2028
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million CHF | 74.51 | 110.23 |
| 125.11% | 47.95% | |
| Net Margin | -5.68% | 1.83% |
| 86.12% | 132.23% |
4 Analysts have issued a sales forecast Kuros Biosciences 2025 . The average Kuros Biosciences sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued an EBITDA forecast Kuros Biosciences 2025 . The average Kuros Biosciences EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Margin
| 2024 | 1.02% | 107.78% |
|---|
4 Kuros Biosciences Analysts have issued a net profit forecast 2025. The average Kuros Biosciences net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share CHF | -0.10 | 0.05 |
| 72.97% | 150.00% | |
| P/E | 506.46 | |
| EV/Sales | 9.13 |
4 Analysts have issued a Kuros Biosciences forecast for earnings per share. The average Kuros Biosciences EPS is
This results in the following potential growth metrics and future valuations:
Kuros Biosciences...
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
